Literature DB >> 29866887

Defining the elusive boundaries of chronic active Epstein-Barr virus infection.

Sebastian Fernandez-Pol1, Oscar Silva1, Yasodha Natkunam2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29866887      PMCID： PMC6058790          DOI： 10.3324/haematol.2018.193714

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  19 in total

1.  Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

Authors:  H Kimura; Y Hoshino; H Kanegane; I Tsuge; T Okamura; K Kawa; T Morishima
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

2.  Immunodeficiency and Dysregulation: Report of the 2015 Workshop of the Society for Hematopathology/European Association for Haematopathology.

Authors:  Yasodha Natkunam; Dita Gratzinger; Daphne de Jong; Amy Chadburn; John R Goodlad; John K C Chan; Jonathan Said; Elaine S Jaffe
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

3.  Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.

Authors:  Can Küçük; Bei Jiang; Xiaozhou Hu; Wenyan Zhang; John K C Chan; Wenming Xiao; Nathan Lack; Can Alkan; John C Williams; Kendra N Avery; Pınar Kavak; Anna Scuto; Emel Sen; Philippe Gaulard; Lou Staudt; Javeed Iqbal; Weiwei Zhang; Adam Cornish; Qiang Gong; Qunpei Yang; Hong Sun; Francesco d'Amore; Sirpa Leppä; Weiping Liu; Kai Fu; Laurence de Leval; Timothy McKeithan; Wing C Chan
Journal:  Nat Commun       Date:  2015-01-14       Impact factor: 14.919

4.  The association of latent Epstein-Barr virus infection with hydroa vacciniforme.

Authors:  K Iwatsuki; Z Xu; M Takata; M Iguchi; M Ohtsuka; H Akiba; Y Mitsuhashi; H Takenoshita; R Sugiuchi; H Tagami; F Kaneko
Journal:  Br J Dermatol       Date:  1999-04       Impact factor: 9.302

5.  Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma.

Authors:  Lu Jiang; Zhao-Hui Gu; Zi-Xun Yan; Xia Zhao; Yin-Yin Xie; Zi-Guan Zhang; Chun-Ming Pan; Yuan Hu; Chang-Ping Cai; Ying Dong; Jin-Yan Huang; Li Wang; Yang Shen; Guoyu Meng; Jian-Feng Zhou; Jian-Da Hu; Jin-Fen Wang; Yuan-Hua Liu; Lin-Hua Yang; Feng Zhang; Jian-Min Wang; Zhao Wang; Zhi-Gang Peng; Fang-Yuan Chen; Zi-Min Sun; Hao Ding; Ju-Mei Shi; Jian Hou; Jin-Song Yan; Jing-Yi Shi; Lan Xu; Yang Li; Jing Lu; Zhong Zheng; Wen Xue; Wei-Li Zhao; Zhu Chen; Sai-Juan Chen
Journal:  Nat Genet       Date:  2015-07-20       Impact factor: 38.330

6.  EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

Authors:  Hiroshi Kimura; Yoshinori Ito; Shinji Kawabe; Kensei Gotoh; Yoshiyuki Takahashi; Seiji Kojima; Tomoki Naoe; Shinichi Esaki; Atsushi Kikuta; Akihisa Sawada; Keisei Kawa; Koichi Ohshima; Shigeo Nakamura
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

7.  Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan.

Authors:  I J Su; R L Chen; D T Lin; K S Lin; C C Chen
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

8.  Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.

Authors:  Leticia Quintanilla-Martinez; Cecilia Ridaura; Florian Nagl; Marimar Sáez-de-Ocariz; Carola Durán-McKinster; Ramon Ruiz-Maldonado; Georgia Alderete; Peter Grube; Carmen Lome-Maldonado; Irina Bonzheim; Falko Fend
Journal:  Blood       Date:  2013-08-27       Impact factor: 22.113

9.  Fatal Epstein-Barr virus-associated hemophagocytic syndrome.

Authors:  H Kikuta; Y Sakiyama; S Matsumoto; T Oh-Ishi; T Nakano; T Nagashima; T Oka; T Hironaka; K Hirai
Journal:  Blood       Date:  1993-12-01       Impact factor: 22.113

10.  A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.

Authors:  Keisuke Kawamoto; Hiroaki Miyoshi; Takaharu Suzuki; Yasuji Kozai; Koji Kato; Masaharu Miyahara; Toshiaki Yujiri; Ilseung Choi; Katsumichi Fujimaki; Tsuyoshi Muta; Masaaki Kume; Sayaka Moriguchi; Shinobu Tamura; Takeharu Kato; Hiroyuki Tagawa; Junya Makiyama; Yuji Kanisawa; Yuya Sasaki; Daisuke Kurita; Kyohei Yamada; Joji Shimono; Hirohito Sone; Jun Takizawa; Masao Seto; Hiroshi Kimura; Koichi Ohshima
Journal:  Haematologica       Date:  2017-12-14       Impact factor: 9.941
View more
  3 in total

1.  Rethinking the elusive boundaries of EBV-associated T/NK-cell lymphoproliferative disorders.

Authors:  Zihang Chen; Pujun Guan
Journal:  Haematologica       Date:  2019-03       Impact factor: 9.941

2.  Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders.

Authors:  Li-Min Gao; Sha Zhao; Wen-Yan Zhang; Mi Wang; Hui-Fang Li; Anle Lizaso; Wei-Ping Liu
Journal:  Cancer Biol Ther       Date:  2019-07-16       Impact factor: 4.742

3.  Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma.

Authors:  Sara Kwong; Xiangping Lu; Xiuli Liu; Jinping Lai
Journal:  Gastroenterology Res       Date:  2020-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.